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Inﬂammatory myoﬁbroblastic tumors (IMTs) are rare childhood neoplasms, with benign clinical course.
Although etiology of IMTs are not clear, recent studies have reported that IMT is a true neoplasm rather
than a reactive or inﬂammatory lesion. IMTs are rarely seen in adults and tracheal involvement is also
rare both in adults and also in children. We describe a 16-year old female patient who was misdiagnosed
and treated as asthma in another center for a few months and presented with acute respiratory distress
due to upper airway obstruction. Computerized tomography (CT) of the chest and rigid bronchoscopy
revealed a mass lesion that was nearly totally obliterating tracheal lumen. Bronchoscopic resection was
performed under general anesthesia and the ﬁnal pathological diagnosis was tracheal IMT.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
IMTs are rare, benign neoplasms and usually encountered in
children under 16 years of age. The natural history of this disease is
poorly understood [1e3]. Although IMTs have been described in
virtually every anatomic location, there are only a few documented
reports with tracheal involvement [4].
Here we report a 16-year old female patient with tracheal IMT
who presented with acute respiratory distress due to upper airway
obstruction.Case report
A 16-year old female patient was admitted to our hospital with
dyspnea and acute respiratory distress. Her medical history was
unremarkable except for asthma that was treated in another
institution for a few months. At presentation, stridor was the onlylupınar University Faculty of
00, Turkey. Tel.: þ90 543 216
Toru).
Ltd. This is an open access article uabnormal ﬁnding on physical examination. Pulmonary function
tests (PFTs) could not be performed because of respiratory distress.
Laboratory data revealed mild leukocytosis and normal compre-
hensive metabolic panel. Arterial blood gas analysis revealed pH:
7.42, PCO2: 35 mm Hg, PO2: 41 mm Hg, SaO2%: 77.8%, HCO3:
22.9 mmol/L. Although postero-anterior (PA) Chest X-Ray was
normal and Thorax CT showed a mass which was nearly totally
obliterating the tracheal lumen (Fig. 1).
Rigid bronchoscopy was performed under general anesthesia
and showed a vascularized, smooth-surfaced, lobulatedmass lesion
that was obliterating tracheal lumen just below the cord vocals
(Fig. 2). The mass was removed with electrocautery snare and the
surrounding area of tumor was coagulated with Argon Plasma
Coagulation (APC). Cryotherapy was performed after APC (Fig. 3).
On clinical follow-up, inspiratory stridor was diminished after the
procedure and PFT values were as follows; FVC: 3.5 L (108.2% of
predicted), FEV1: 3.3 L (121.8% of predicted), FEV1/FVC: 95.59%.
Immunohistochemical studies were performed in addition to
routine histologic examination and histological ﬁndings of the
lesion showed a positivity for vimentin, smoothmuscle actin (SMA)
and Ki-67 that was accompanied by myoﬁbroblastic spindle cells
and inﬂammatory cell inﬁltration. Pathological diagnosis of the
mass was consistent with IMT.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Chest CT image of the mass lesion which was obliterating tracheal lumen.
Fig. 3. Broncoscopic view after endoscopic resection, APC and criyotherapy.
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raphy (PET)eCT showed local involvement around the resection
site and there was no distant metastasis. A thoracotomy with
segmental tracheal resection was planned. Because the patient did
not accept the treatment she was discharged homewith the plan of
close follow-up in the clinic.
Discussion
World Health Organization recognizes IMTas a distinctive lesion
composed of a myoﬁbroblastic spindle cell population accompa-
nied by an inﬂammatory inﬁltrate of plasma cells, lymphocytes,
and eosinophils [4].
Because of its histopathological character IMTs have also been
named as plasma cell granuloma, ﬁbrous histiocytoma, xanthog-
ranuloma, or inﬂammatory pseudotumor, but it is popularly knownFig. 2. Bronchoscopic view of vascularized, smooth-surfaced, lobulated mass lesion
that was obliterating tracheal lumen after cord vocals.as inﬂammatory pseudotumor. It is a slow-growing quasi-
neoplastic lesion. Although its clinical course is benign it can mimic
malignancy both clinically and radiologically [5,6].
Recently, rare cases with aggressive clinical picture, such as local
recurrence, malignant transformation, or distant metastasis, were
reported. Now it is believed that IMTs are low-grade mesenchymal
malignancies [4]. However the overall prognosis is generally
excellent [2,7].
Although the lung is the most common site for these tumors,
IMTs may also develop in other sites such as stomach, orbit, mes-
entery, heart, gastrointestinal tract, adrenal gland and central ner-
vous system [3,6,8e10]. Lung IMTs are rare in adults although they
represent one of the most common lung tumors in pediatric pop-
ulation. Their frequency is 0.04%e0.07%. IMTs constitute of 20% of
all primary lung tumors and 57% of all benign lung tumors [11e13].
Based on the locationwithin the chest, IMTs are divided into two
groups as parenchymal and airway IMTs. Most IMTs manifest as a
solitary lesion in the lung parenchyma, and only 10% of these
develop within the airway that usually present with early respi-
ratory symptoms [14]. Involvement of trachea and bronchi consti-
tutes of 6.7% of cases, and trachea alone is extremely rare with only
2.7% of all reported cases [12,13].
As we see from the literature airway IMTs, especially those with
tracheal involvement, are rarely seen in both adults and children
therefore our 16-years old case is an example of this rare tracheal
entity.
Although the etiology of IMTs is not understood, it is thought
that they may be a result of the inﬂammation following a minor
trauma or surgery. Associationwith malignancy or an autoimmune
process have also been described [4,15,16]. A study by Marsubara
et al. reported the possibility of infection as a triggering factor for
IMT since all of their 32 cases were originated from organizing
pneumonia [17]. On the other hand, our patient did not have history
of trauma or surgery or evidence of infection.
Applebaum et al. proposed that COX2 and VEGF, as mediators of
angiogenesis, may play a role in the pathogenesis and growth of
IMTs [18]. Although previous studies have suggested that IMTs
could be inﬂammatory, and reactive lesions which develop as a
consequence of some type of pulmonary infection, recent studies
suggested that they are true neoplasms rather than a purely in-
ﬂammatory or reactive lesion because of the presence of clonal
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anaplastic lymphoma kinase (ALK) receptor tyrosine-kinase gene
locus or fusion of ALK with the clathrin heavy chain gene localized
on 17q23 [19,20].
The symptoms of IMTs are usually nonspeciﬁc and depends on
the location, including dyspnea, stridor, chronic cough, hemoptysis,
and pleuritic chest pain. In the small number of patients with
endobronchial lesions, the clinical presentation may be acute and
serious due to post-obstructive pneumonia or symptoms associ-
ated with airway obstruction. Some cases have been misdiagnosed
and treated as asthma [4,21]. Our patient had typical symptoms of
upper airway obstruction such as stridor and severe respiratory
distress. She also carried a diagnosis of asthma which we believe
was not the case since her symptoms improved after treatment.
Radiographic investigation with PA and left lateral chest radio-
grams, CT imaging and endoscopy are the essential methods in
diagnostic workup of every obstructive tracheal lesion [2]. In our
case we performed PA chest radiogram and Chest CT for radiolog-
ical evaluation. While chest radiogram was unremarkable, CT
showed a mass lesion that was nearly totally obliterating the
proximal tracheal lumen.
IMTs should be in the differential diagnosis of tracheal tumors
and a tissue biopsy is necessary for a deﬁnitive diagnosis of IMT
[6,22].
Immunohistochemical analysis of the biopsy demonstrates a
positivity for vimentin, muscle-speciﬁc actin, SMA and cytokeratin
which are characteristic for myoﬁbroblasts [10]. Immunohisto-
chemical analysis of the tumor in our case showed a positivity for
vimentin and SMA with myoﬁbroblastic spindle cells and inﬂam-
matory cell inﬁltration. Final pathological diagnosis was IMT.
While the treatment of IMT used to be wide local excision and
radiation therapy reserved for recurrences in the past, the current
approach to treatment is conservative surgery. Ramachandra et al.
reported their experiences of 18 cases of soft tissue IMTs and
underlined that simple surgical resection was curative in the
treatment of these lesions [2,7,23,24].
Recurrence can occur after resection so local excisionwith a rim
of normal tissue should be performed to decrease the rate of
recurrence [21,23,24]. Cofﬁn et al. reported a recurrence rate of 25%
in those with incomplete resection and the overall aggressive
behavior of IMTs in their series was related to the anatomic site,
proximity of the tumor to vital structures, and multinodarity of the
lesion, all of which required deﬁnitive resection [10].
Although the usual treatment for this entity is surgical excision,
endoscopic resection may be an adequate approach when the tu-
mor is completely endoluminal [21].
For tracheal lesions, CO2 laser or electrocautery has been suc-
cessful with no need for tracheal resection. Low-dose radiotherapy
(RT) has been found to be successful in a small number of cases
especially those tumors predominantly with lymphoplasmacytic
cell inﬁltration rather than ﬁbrous tissue. RT is reserved as a last
resort in treatment when surgery is no feasible [2,9,22,24].
Recently, some studies showed succesful results with steroids as
initial therapy in tumors outside the orbit. Chemotherapy in the
form of cyclosporine, methotrexate, azothioprine, and cyclophos-
phamide has been used only in those with malignancy on pathol-
ogy or distant metastasis with various results [7,9,22].
A long-term follow-up is essential in the management of IMTs
and follow-up should be at regular intervals during the ﬁrst few
years because most recurrences will occur within one year of initial
surgery, with only a few reports of late recurrences in the literature
[2,23,24].
The obstructing tracheal mass in our case was removed by using
electrocautery snare. After coagulation was achieved with APC,
cryotherapy was done for the remaining endoluminal lesions.Following endobronchial resection and the diagnosis of IMT, we
performed PET-CT and local involvement was detected around the
resection site. We did not use steroids, RT or chemotherapy as
further treatment options in our case because there was no diag-
nosis of malignancy or any evidence of distant metastasis according
to histopathological and radiological evaluation. We offered tho-
racotomy with local excision of the involved trachea however our
patient declined the surgical approach but agreed to be followed in
the clinic.
In summary, the surgical resection has been the most relevant
treatment for tracheal IMTs. Resection of these tumors can be
performed either bronchoscopically by using debulking methods
such as CO2 laser, electrocautery, or open surgical interventionwith
segmental tracheal resection. If the lesion is completely endolu-
minal based on imaging studies, endoscopic resection is suggested.
Radical surgery and/or adjuvant RT and chemotherapy are not
indicated unless the disease is malignant or metastasized [4,21].
Consequently, it is important to consider tracheal IMT in the
differential diagnosis of cases with respiratory distress due to upper
airway obstruction. IMTs can mimic malignancies both clinically
and radiologically but if there is a prediagnosis of IMT, clinicians
must be cautious not to perform a radical surgery until the ﬁnal
pathologic diagnosis is completed. There are several treatment
options but complete extirpation of the lesion is desirable if the
tumor is completely endoluminal and endoscopic resection is the
current treatment of choice with excellent results.
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